# Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy

Study · id `cardio:ct-nct05366101` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05366101](<https://clinicaltrials.gov/study/NCT05366101>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05366101

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 168 participants.

## Technical summary

Registry record NCT05366101. Randomized; no masking; primary purpose supportive care. Start 2019-04-01 (actual); primary completion 2022-02-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose supportive care
- Phase: Phase 2/3
- Enrolled: 168 participants (enrolled count; ClinicalTrials.gov record NCT05366101, source copy `cardio:ctgov-nct05366101-2022-05-09`, retrieved 2026-10-31)
- Started: 2019-04-01 (actual) (ClinicalTrials.gov record NCT05366101, source copy `cardio:ctgov-nct05366101-2022-05-09`, retrieved 2026-10-31)
- Primary completion: 2022-02-28 (actual) (ClinicalTrials.gov record NCT05366101, source copy `cardio:ctgov-nct05366101-2022-05-09`, retrieved 2026-10-31)
- Completion: 2022-03-31 (actual) (ClinicalTrials.gov record NCT05366101, source copy `cardio:ctgov-nct05366101-2022-05-09`, retrieved 2026-10-31)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05366101, source copy `cardio:ctgov-nct05366101-2022-05-09`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05366101-2022-05-09`, retrieved 2026-10-31)

## The registry's words

- Brief title: Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
- Acronym: SILICOFCM
- Condition: Hypertrophic Cardiomyopathy
- Intervention (Drug): Sacubitril/Valsartan
- Intervention (Behavioral): Lifestyle
- Lead sponsor: Newcastle-upon-Tyne Hospitals NHS Trust
- Lead sponsor class: OTHER
- Collaborator: University Hospital Regensburg
- Collaborator class: OTHER
- Collaborator: Assistance Publique - Hôpitaux de Paris
- Collaborator class: OTHER
- Collaborator: Azienda Ospedaliero-Universitaria Careggi
- Collaborator class: OTHER
- Collaborator: Institute of Cardiovascular Diseases, Vojvodina
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry condition terms include this condition: Hypertrophic cardiomyopathy (`cardio:hypertrophic-cardiomyopathy`)
- Registry lists this organization as a collaborator: Assistance Publique - Hôpitaux de Paris (`cardio:org-assistance-publique-hopitaux-de-paris`)
- Registry lists this organization as a collaborator: Azienda Ospedaliero-Universitaria Careggi (`cardio:org-azienda-ospedaliero-universitaria-careggi`)
- Registry lists this organization as a collaborator: Institute of Cardiovascular Diseases, Vojvodina (`cardio:org-institute-of-cardiovascular-diseases-vojvodina`)

## Provenance

Content hash: 804e3cad8d489098bef00ff4e37d9b43c574363f4246da39317937e103566b33
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
